Visudyne® in Occult (VIO)
NCT00121407
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
364
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Visudyne for injection
Sponsor
QLT Inc.